Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits by Antic, Vladan et al.
Role of the Sympathetic Nervous System
During the Development of Obesity-induced
Hypertension in Rabbits
Vladan Antic, Francesca Kiener-Belforti, Aldo Tempini, Bruce N. Van Vliet, and
Jean-Pierre Montani
We have previously reported that weight gain
induced by high-fat diet (HFD) leads to an increase
in mean arterial pressure (MAP, 114%) and heart
rate (HR, 131%) in the adult rabbit. In the present
study, we tested the hypothesis that an increased
activity of the sympathetic nervous system may
contribute to the development of obesity-induced
hypertension. A combination of a- and b-
adrenergic blockers (terazosin 1 propranolol) was
chronically administered to rabbits housed in
metabolic cages for continuous monitoring of
arterial pressure by telemetry, 24 h a day. After 2
weeks of adrenergic blockade under control diet,
animals were switched to HFD for the next 6
weeks. HFD induced a progressive increase in
body weight, but no increase in mean arterial
pressure (10.2 6 2.5%) and a slight increase in
heart rate (114 6 3%). Time-control animals fed
normal diet showed no changes in MAP or HR
with long-term a- and b-adrenergic blockade. Our
results indicate that the activation of the
sympathetic nervous system may play an important
role in the pathogenesis of obesity-induced
hypertension. Am J Hypertens 2000;13:556–559
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The association between obesity and hyper-tension has been recognized for many de-cades. However, the basic physiologic mech-anisms that link body weight and blood
pressure are still incompletely understood. Several
lines of evidence indicate that the activity of the sym-
pathetic nervous system may be elevated in obesity.
First, a correlation between blood pressure and nor-
epinephrine levels has been shown in borderline obese
hypertensive subjects and during blood pressure re-
duction induced by weight loss.1 Second, increased
caloric intake activates the sympathetic nervous sys-
tem, whereas fasting reduces sympathetic activity.2
Third, in healthy humans, body fat is a major deter-
minant of the resting rate of muscle sympathetic nerve
discharge.3 Finally, studies in dogs4,5 support the im-
portance of sympathetic activation during rapid
weight gain as a plausible mechanism contributing to
the increased blood pressure.
Adult rabbits fed an ad libitum high-fat diet (HFD)
represent an attractive and promising model to study
the mechanisms of obesity-induced hypertension.
These rabbits exhibit hemodynamic and neurohu-
moral changes that mimic changes observed in human
obesity, including hypertension, a hyperdynamic
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circulation with increased heart rate and cardiac out-
put, elevations in plasma insulin and plasma renin
activity, cardiac hypertrophy, and impaired diastolic
function, as reported previously.6,7
Recently, we have studied the sequential cardiovas-
cular and renal changes that occur in rabbits during
weight gain induced by a HFD.8 HFD induced a rapid
increase in mean arterial pressure, heart rate, and
glomerular filtration rate that stabilized, respectively,
at 14%, 31%, and 68% above control values. The model
was also characterized by a net accumulation of so-
dium, with significant sodium retention during the
first 3 weeks of HFD. Time-course analysis of the
changes in blood pressure in this model suggests that
obesity-induced hypertension may consist of two
phases: the early phase could be due to high-fat intake
or overfeeding, whereas the later phase seems to be
strongly related to weight gain and increased fat mass.
To test the hypothesis that an increased activity of
the sympathetic system may play a role in both the
early and later phases of obesity-induced hyperten-
sion, we studied freely moving rabbits during the
development of obesity while sympathetic activity
was blocked pharmacologically. To that purpose, we
administered a combination of a- and b-adrenergic
antagonists, to block the peripheral vasoconstrictor
actions and direct renal tubular effects of sympathetic
activation, and to prevent the sympathetically medi-
ated stimulation of the heart and of renin release.
MATERIALS AND METHODS
Animal Preparation Adult male lop-eared rabbits
(body weight 4.33 6 0.10 kg) of the breed “Be´lier
Franc¸ais” were used in this study. All protocols were
approved by the State Animal Committee. Under
halothane anesthesia and aseptic techniques, the rab-
bits were instrumented with an implantable pressure
transducer and radiotransmitter (model TA11PA-C40,
Data Sciences International, St. Paul, MN) to monitor
arterial pressure by telemetry, as described previous-
ly.8 After surgery, the rabbits were housed in individ-
ual cages, customized for urine collection, in a quiet
air-conditioned room with a 12-h light–dark cycle.
The rabbits were allowed to recover for at least 10
days before the start of the experiments. All animals
had free access to tap water and were fed 180 g of
standard rabbit chow per day.
Continuous Hemodynamic Monitoring by Teleme-
try Each metabolic cage was equipped with receivers,
connected by a multiplexer to a calibrated pressure an-
alog adapter, as described previously.8 The analog pres-
sure signal was then sent to an A/D converter and
processed by a personal computer using customized
algorithms9 to compute mean arterial pressure (MAP)
and heart rate (HR) on a beat-to-beat basis. The signal
was sampled at 500 Hz, for 5-sec periods every 30 sec,
from 10:00 am to 8:00 am the next morning. Weekly
results are reported as the average of 7 consecutive days.
Experimental Protocol After 1 week of control mea-
surements rabbits were given a combination of a- and
b-adrenergic blockers for the next 8 weeks. Terazosin
monohydrochloride (Abbott Laboratories, Abbott
Park, IL) and dl-propranolol (Sigma, St. Louis, MO)
were added to the drinking water and the concentra-
tion was adjusted according to the average water in-
take of the animals to assure a daily drug intake of
’20 mg/kg of each substance. To test the adequacy of
the sympathetic blockade, we analyzed the cardiovas-
cular response to the intravenous injection (through
an ear vein) of an a-adrenergic agonist (phenylephrine
16 mg/kg) or a b-adrenergic agonist (isoproterenol
0.05 mg/kg) before and during a and b blockade.
After 2 weeks of sympathetic blockade, the rabbits
(n 5 5) were switched to a HFD ad libitum (standard
rabbit chow with 10% added fat as soya oil-to-pork fat
1:1) for another 6 weeks. Three additional rabbits were
treated with adrenergic blockers for 8 weeks, but were
kept on the standard rabbit chow to serve as time-
controls. Water intake, food intake, and 24-h urine
output were determined daily at ’9:00 am. Body
weight was measured twice a week. Blood samples
were withdrawn weekly by arterial puncture of the
central ear artery for various analytic measurements.
Analytical Measurements Plasma and urine sodium
and potassium were determined by flame photometry
(model IL 943, Instruments Laboratoires, Lexington,
MA), and creatinine by the kinetics of Jaffe´ (Beckman
creatinine analyzer 2, Fullerton, CA). Glomerular filtra-
tion rate (GFR) was assessed based on creatinine clear-
ance. Sodium balance was calculated as the difference
between sodium intake and urinary sodium excretion,
taking into account an average of 20% nonrenal (fecal)
loss of sodium (results from separate experiments), con-
sistent with values reported by Grace et al.10
Statistical Analysis Statistical analysis within group
was performed by analysis of variance for repeated mea-
surements. Because each rabbit within a group serves as
its own control, experimental values were compared
with control values in each group using Dunnett’s mul-
tiple comparison procedure. Changes were considered
to be statistically significant if P , .05.
RESULTS
In the five pre-HFD rabbits, combined a and b blockade
resulted in an immediate decrease in MAP from 66.1 6
2.1 mm Hg to 59.3 6 2.0 mm Hg (211.2 6 2.0%) on day
1, but MAP increased slowly over the next few days to
plateau at 63.9 6 1.9 mm Hg (23.3 6 2.0%) during the
second week of pharmacologic blockade. Sympathetic
AJH–MAY 2000–VOL. 13, NO. 5, PART 1 SYMPATHETIC BLOCKADE AND OBESITY 557
blockade induced the same changes in MAP in time-
control rabbits (n 5 3). The adequacy of sympathetic
blockade was assessed by pharmacologic tests. Before
blockade, intravenous phenylephrine (16 mg/kg) in-
creased MAP by 37.8 6 0.5 mm Hg, whereas intrave-
nous isoproterenol (0.05 mg/kg) increased HR by 71.4 6
7.2 beats/min. During long-term blockade, the increases
in MAP and HR induced by phenylephrine and isopro-
terenol were only 13.2 6 1.9 mm Hg and 8.8 6 3.1
beats/min, respectively.
Figure 1 illustrates the sequential changes in MAP,
HR, and sodium balance during 6 weeks of HFD diet
(n 5 5) or normal diet (n 5 3) during sympathetic
blockade. In Figure 1, the control week (week 0, 100%)
corresponds to the second week of pharmacologic block-
ade, with values of MAP and HR of 63.9 6 1.9 mm Hg
and 195 6 5 beats/min in the HFD group (n 5 5), and
59.3 6 1.1 mm Hg and 182 6 6 beats/min in the time-
control group (n 5 3). Despite a progressive increase in
body weight from 4.46 6 0.12 kg to 5.41 6 0.23 kg in
HFD rabbits, MAP remained unchanged throughout the
pharmacologic blockade (63.8 6 1.3 mm Hg at week 6 of
HFD, or 0.2 6 2.5% above control). In contrast, HR
increased immediately with HFD (214 6 4 beats/min or
110 6 3%, week 1) and remained elevated throughout
HFD (222 6 8 beats/min or 114 6 3%, week 6). In
time-control rabbits fed a normal diet, MAP and HR
remained stable throughout the experimental protocol
(60.6 6 0.6 mm Hg and 182 6 8 beats/min, respectively,
during the last experimental week). The changes in
MAP, HR, and sodium balance from our previous
study8 (intact rabbits without sympathetic blockade, fed
an HFD) are included in Figure 1 for comparison.
Two weeks of combined a and b blockade increased
GFR from 10.2 6 0.8 to 12.2 6 1.3 mL/min (118.4 6
4.1%), but this change did not reach statistical signifi-
cance (n 5 5). Similar changes were observed in time-
control rabbits, from 9.8 6 0.4 mLmin to 11.7 6 0.8
mL/min (118.4 6 7.2%). However, when data of both
groups were pooled (n 5 8), the increase in GFR was
significant after 2 weeks of blockade. In the HFD group,
a further increase of GFR to 13.7 6 0.8 mL/min was
observed, but the change was only significant when
compared to the period before blockade. GFR remained
stable in our time-control rabbits (11.8 6 1.7 mL/min).
Finally, analysis of sodium balance in HFD rabbits
showed a slight but statistically nonsignificant tendency
for sodium retention with the HFD. In contrast, potas-
sium balance data in HFD rabbits (computed as potas-
sium intake minus urinary potassium excretion) showed
potassium retention over the entire experimental period.
Sodium and potassium balances remained stable in
time-control rabbits.
DISCUSSION
The most significant finding of the present study is that
pharmacologic blockade of the sympathetic nervous sys-
tem with a selective a1-antagonist (terazosin) and a non-
specific b-receptor antagonist (propranolol) prevents the
increase in MAP induced by a high-fat, high-calorie diet
in rabbits. In our previous study,8 we reported that rab-
bits fed an ad libitum HFD showed a rapid increase in
MAP already after 3 days of HFD (19%) that stabilized
at 14% above control over the next 7 weeks. Sympathetic
blockade appeared to block both the early and late in-
crease in blood pressure, suggesting that an activation of
the sympathetic nervous system is involved in both
phases of obesity-induced hypertension.
FIGURE 1. Percent changes in mean arterial pressure (MAP),
heart rate (HR), and sodium balance in rabbits submitted to 6 weeks
of high-fat diet (solid line, closed symbols) or in time-control rabbits
(solid line, open symbols) during a 1 b-adrenergic blockade. Average
sodium balance during the control period was subtracted from the
subsequent weekly averages. Values are expressed as mean 6 SE. The
dotted line shows the changes observed in high-fat diet animals
without sympathetic blockade (from our previous study8).
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Interestingly, the increased HR (131%) induced by
HFD alone8 was not completely suppressed by sympa-
thetic blockade, but simply attenuated (114%). If one
assumes effective b blockade as evidenced by our iso-
proterenol challenge tests, those data suggest that mech-
anisms other than cardiac sympathetic activation are
partially responsible for the tachycardia observed in this
model of hypertension. Possible mechanisms include a
metabolically mediated increase in intrinsic HR or a
reduction in vagal tone as has been observed in obese
dogs.11 Our renal data are also consistent with an overall
sympathetic hyperactivity in obesity-induced hyperten-
sion. In the present study, sympathetic blockade mark-
edly attenuated the sodium retention observed in rabbits
during weight gain.8 In the intact animals, an increase in
plasma renin activity, as observed in obese dogs12 and
rabbits,6 and direct tubular effects of sympathetic activa-
tion,13 may both contribute to sodium retention. There-
fore, inhibition of these mechanisms may explain the
observed attenuation of sodium retention.
The marked increase in GFR by HFD alone8 was also
attenuated in the present study. As in other studies12, we
postulated that the increase in GFR in intact obese ani-
mal models could be related to an increased tubular
reabsorption at a site proximal to the macula densa,
resulting in a compensatory increase in GFR. Decreased
tubular reabsorption induced by sympathetic blockade
would thus minimize the increase in GFR. An alternate
explanation is that sympathetic blockade alone increased
GFR by 18%, which could have blunted a further in-
crease in GFR with HFD.
Our study in rabbits is also in accordance with obser-
vations on the role of sympathetic nervous system in
obese dogs. Combined adrenergic blockade for 7 days
decreases blood pressure to a greater extent in obese
dogs compared to lean dogs,4 and bilateral renal dener-
vation attenuates the sodium retention and hypertension
associated with obesity.14 Recently, Rocchini et al5 have
shown that clonidine, a central a2 agonist that inhibits
central nervous sympathetic activity, prevents insulin
resistance and hypertension in obese dogs.
The mechanisms by which weight gain leads to
sympathetic activation are not yet fully understood,
but an interesting candidate is leptin. Leptin produc-
tion correlates positively with body mass index and
chronic leptin infusion increases both blood pressure
and heart rate in rats,15 probably through sympathetic
activation.16 In addition, leptin is unable to increase
blood pressure and HR in rats during combined a and
b blockade.17 In summary, our study suggests an im-
portant role of the sympathetic nervous system during
the development of obesity-induced hypertension.
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